SHL earnings climb to SAR 15.8M in 9M 2024, SAR 5.1M in Q3 9 M 2024 SHL logs net profit of SAR 10.7M in H1 2024; Q2 at SAR 6M 6 M 2024 SHL profit soars 89% to SAR 4.6M in Q1 2024 3 M 2024 SHL 2023 ...

for ADI-001 for the treatment of refractory systemic lupus erythematosus (SLE) with extrarenal involvement. The Company is evaluating ADI-001 across six autoimmune indications. Patient enrollment ...

SHL Telemedicine provides this device as part of its telemedicine service to those of its users suffering from respiratory problems and/or from chronic lung conditions affecting air movement in ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market First-in-human Phase 1/1b single/multiple dose study in ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

IFGL Refractories Ltd., incorporated in the year 2007, is a Small Cap company (having a market cap of Rs 1,419.59 Crore) operating in Industrial Consumables sector. IFGL Refractories Ltd. key Products ...

2288.T Marudai Food Co., Ltd.

Provision of medical diagnostic services and the provision of administrative services and facilities to medical practitioners.

RHI Magnesita India Ltd. key Products/Revenue Segments include Refractories, Income From Management Services, Sale of services and Other Operating Revenue for the year ending 31-Mar-2024.For the ...